{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T05:12:48Z","timestamp":1792300368263,"version":"4.4.0"},"reference-count":148,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,6,28]],"date-time":"2016-06-28T00:00:00Z","timestamp":1467072000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Current Ophthalmology"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.joco.2016.09.009","type":"journal-article","created":{"date-parts":[[2016,10,20]],"date-time":"2016-10-20T10:47:38Z","timestamp":1476960458000},"page":"7-16","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":124,"title":["Therapeutic targets of renin-angiotensin system in ocular disorders"],"prefix":"10.4103","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8627-3613","authenticated-orcid":false,"given":"Rajesh","family":"Choudhary","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mandeep Singh","family":"Kapoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amrita","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surendra H.","family":"Bodakhe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"10.1016\/j.joco.2016.09.009_bib1","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/j.1365-2796.2008.01981.x","article-title":"Renin-angiotensin system revisited","volume":"264","author":"Fyhrquist","year":"2008","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.joco.2016.09.009_bib2","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1177\/1470320314549791","article-title":"Expression of classical components of the renin-angiotensin system in the human eye","volume":"16","author":"White","year":"2015","journal-title":"J\u00a0Renin Angiotensin Aldosterone Syst"},{"key":"10.1016\/j.joco.2016.09.009_bib3","first-page":"RA194","article-title":"Angiotensin II and vascular inflammation","volume":"11","author":"Cheng","year":"2005","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.joco.2016.09.009_bib4","doi-asserted-by":"crossref","first-page":"281","DOI":"10.3109\/10641969509087071","article-title":"Angiotensin as neuromodulator\/neurotransmitter in central control of body fluid and electrolyte homeostasis","volume":"17","author":"Culman","year":"1995","journal-title":"Clin Exp Hypertens"},{"key":"10.1016\/j.joco.2016.09.009_bib5","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1210\/en.2013-2011","article-title":"Adiponectin suppresses angiotensin II-induced inflammation and cardiac fibrosis through activation of macrophage autophagy","volume":"155","author":"Qi","year":"2014","journal-title":"Endocrinology"},{"key":"10.1016\/j.joco.2016.09.009_bib6","doi-asserted-by":"crossref","first-page":"S95","DOI":"10.1046\/j.1523-1755.1998.06719.x","article-title":"Physiological and pharmacological implications of AT1 versus AT2 receptors","volume":"67","author":"Chung","year":"1998","journal-title":"Kidney Int"},{"key":"10.1016\/j.joco.2016.09.009_bib7","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1046\/j.1523-1755.2000.00427.x","article-title":"Angiotensin type 2 receptor is expressed in the adult rat kidney and promotes cellular proliferation and apoptosis","volume":"58","author":"Cao","year":"2000","journal-title":"Kidney Int"},{"key":"10.1016\/j.joco.2016.09.009_bib8","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1172\/JCI118807","article-title":"Chronic blockade of AT2-subtype receptors prevents the effect of angiotensin II on the rat vascular structure","volume":"98","author":"Levy","year":"1996","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.joco.2016.09.009_bib9","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/S0002-9440(10)63448-7","article-title":"Retinal angiogenesis is mediated by an interaction between the angiotensin type 2 receptor, VEGF, and angiopoietin","volume":"163","author":"Sarlos","year":"2003","journal-title":"Am J Pathol"},{"key":"10.1016\/j.joco.2016.09.009_bib10","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0303-7207(00)00406-8","article-title":"Control of renin secretion from adrenal gland in transgenic Ren-2 and normal rats","volume":"173","author":"Rong","year":"2001","journal-title":"Mol Cel Endocrinol"},{"key":"10.1016\/j.joco.2016.09.009_bib11","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0303-7207(02)00217-4","article-title":"Characterization of a thymic renin-angiotensin system in the transgenic m(Ren-2)27 rat","volume":"194","author":"Wilkinson-Berka","year":"2002","journal-title":"Mol Cel Endocrinol"},{"key":"10.1016\/j.joco.2016.09.009_bib12","first-page":"14","article-title":"Renin angiotensin system hyperactivation can induce inflammation and retinal neural dysfunction","volume":"581695","author":"Kurihara","year":"2012","journal-title":"Int J Inflam"},{"key":"10.1016\/j.joco.2016.09.009_bib13","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1210\/jcem-68-1-160","article-title":"Renin, prorenin, and immunoreactive renin in vitreous fluid from eyes with and without diabetic retinopathy","volume":"68","author":"Danser","year":"1989","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.joco.2016.09.009_bib14","first-page":"1749","article-title":"Ocular renin-angiotensin: immunohistochemical evidence for the presence of prorenin in eye tissue","volume":"29","author":"Sramek","year":"1988","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.joco.2016.09.009_bib15","doi-asserted-by":"crossref","first-page":"945","DOI":"10.3109\/02713689309020401","article-title":"Ocular rennin angiotensin: immunocytochemical localization of prorenin","volume":"12","author":"Wallow","year":"1993","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.joco.2016.09.009_bib16","first-page":"1450","article-title":"Renin-containing Muller cells of the retina display endocrine features","volume":"36","author":"Berka","year":"1995","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.joco.2016.09.009_bib17","doi-asserted-by":"crossref","first-page":"755","DOI":"10.3109\/02713689409047011","article-title":"Renin mRNA is synthesized locally in rat ocular tissues","volume":"13","author":"Brandt","year":"1994","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.joco.2016.09.009_bib18","doi-asserted-by":"crossref","first-page":"F396","DOI":"10.1152\/ajprenal.00576.2009","article-title":"Regulation of the renin expression in the retinal pigment epithelium by systemic stimuli","volume":"299","author":"Milenkovic","year":"2010","journal-title":"Am J Physiol Ren Physiol"},{"key":"10.1016\/j.joco.2016.09.009_bib19","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1089\/jop.1996.12.299","volume":"12","author":"Ramirez","year":"1996","journal-title":"J\u00a0Ocul Pharmacol Ther"},{"key":"10.1016\/j.joco.2016.09.009_bib20","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1136\/bjo.80.2.159","article-title":"Demonstration of renin mRNA, angiotensinogen mRNA, and angiotensin converting enzyme mRNA expression in the human eye: evidence for an intraocular renin-angiotensin system","volume":"80","author":"Wagner","year":"1996","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.joco.2016.09.009_bib21","first-page":"1008","article-title":"Angiotensin levels in the eye","volume":"35","author":"Danser","year":"1994","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.joco.2016.09.009_bib22","first-page":"1027","article-title":"Vitreous level of angiotensin-II in patients with diabetic retinopathy","volume":"32","author":"Goel","year":"1991","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.joco.2016.09.009_bib23","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1159\/000081633","article-title":"Immunohistochemical localization of angiotensin-converting enzyme, angiotensin II and angiotensin AT1 receptor in human ocular tissues","volume":"36","author":"Savaskan","year":"2004","journal-title":"Ophthalmic Res"},{"key":"10.1016\/j.joco.2016.09.009_bib24","doi-asserted-by":"crossref","first-page":"3301","DOI":"10.1167\/iovs.06-1024","article-title":"Angiotensin II and its receptor subtypes in the human retina","volume":"48","author":"Senanayake","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.joco.2016.09.009_bib25","doi-asserted-by":"crossref","first-page":"28","DOI":"10.2174\/1874364101509010028","article-title":"Angiotensin(1\u20137) and ACE2, \u201cThe hot spots\u201d of renin-angiotensin system, detected in the human aqueous humor","volume":"9","author":"Holappa","year":"2015","journal-title":"Open Ophthalmol J"},{"key":"10.1016\/j.joco.2016.09.009_bib26","first-page":"876","article-title":"Angiotensin-converting enzyme in bovine, feline, and human ocular tissues","volume":"29","author":"Ferrari","year":"1988","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.joco.2016.09.009_bib27","first-page":"589","article-title":"Angiotensin converting enzyme (ACE) activity in porcine ocular tissue: effects of diet and ACE inhibitors","volume":"19","author":"Geng","year":"2003","journal-title":"J\u00a0Pharm Ther"},{"key":"10.1016\/j.joco.2016.09.009_bib28","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0014-4835(80)90010-X","article-title":"Angiotensin I converting enzyme (kininase II) in ocular tissues","volume":"30","author":"Igic","year":"1980","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.joco.2016.09.009_bib29","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/0014-4835(78)90042-8","article-title":"Renin angiotensin system in the aqueous humor of rabbits, dogs and monkeys","volume":"27","author":"Ikemoto","year":"1978","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.joco.2016.09.009_bib30","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1755-3768.1987.tb08486.x","article-title":"Concentration of angiotensin-converting enzyme in tears of patients with sarcoidosis","volume":"65","author":"Immonen","year":"1987","journal-title":"Acta Ophthalmol Copenh"},{"key":"10.1016\/j.joco.2016.09.009_bib31","first-page":"36","article-title":"Renin-angiotensin system in proliferative diabetic retinopathy and its gene expression in cultured human Muller cells","volume":"47","author":"Kida","year":"2003","journal-title":"J\u00a0Ophthalmol"},{"key":"10.1016\/j.joco.2016.09.009_bib32","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1080\/02713680490516161","article-title":"Measurement of activities in two different angiotensin II generating systems, chymase and angiotensin-converting enzyme, in the vitreous fluid of vitreoretinal diseases: a possible involvement of chymase in the pathogenesis of macular hole patients","volume":"29","author":"Maruichi","year":"2004","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.joco.2016.09.009_bib33","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1001\/archopht.1983.01040010559004","article-title":"Determination of angiotensin converting enzyme in tears: a noninvasive test for evaluation of ocular sarcoidosis","volume":"101","author":"Sharma","year":"1983","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.joco.2016.09.009_bib34","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1440-1681.1997.tb01814.x","article-title":"Angiotensin II generating system in dog and monkey ocular tissues","volume":"24","author":"Shiota","year":"1997","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.joco.2016.09.009_bib35","first-page":"2209","article-title":"Localisation of angiotensin converting enzyme in the ciliary epithelium of the rat eye","volume":"30","author":"Strittmatter","year":"1989","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.joco.2016.09.009_bib36","first-page":"255","article-title":"Angiotensin converting enzyme activity in ocular fluids","volume":"20","author":"Vita","year":"1981","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.joco.2016.09.009_bib37","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/0024-3205(79)90013-4","article-title":"Angiotensin I converting enzyme (kininase II) in isolated retinal microvessels","volume":"24","author":"Ward","year":"1979","journal-title":"Life Sci"},{"key":"10.1016\/j.joco.2016.09.009_bib38","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1001\/archopht.1985.01050010038013","article-title":"Angiotensin converting enzyme activity in human aqueous humor","volume":"103","author":"Weinreb","year":"1985","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.joco.2016.09.009_bib39","doi-asserted-by":"crossref","first-page":"4001","DOI":"10.1167\/iovs.02-1193","article-title":"Captopril inhibits glucose accumulation in retinal cells in diabetes","volume":"44","author":"Zhang","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.joco.2016.09.009_bib40","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1089\/jop.2008.0081","article-title":"Activities of angiotensin-converting enzymes ACE1 and ACE2 and inhibition by bioactive peptides in porcine ocular tissues","volume":"25","author":"Luhtala","year":"2009","journal-title":"J\u00a0Ocul Pharmacol Ther"},{"key":"10.1016\/j.joco.2016.09.009_bib41","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1080\/02713680490517944","article-title":"Identification of angiotensin converting enzyme 2 in the rodent retina","volume":"29","author":"Tikellis","year":"2004","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.joco.2016.09.009_bib42","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1167\/iovs.05-1458","article-title":"Suppression of ocular inflammation in endotoxin-induced uveitis by inhibiting nonproteolytic activation of prorenin","volume":"47","author":"Satofuka","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.joco.2016.09.009_bib43","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.2741\/e163","article-title":"Prorenin and the (pro) renin receptor: do they have a pathogenic role in the retina?","volume":"2","author":"Wilkinson-Berka","year":"2010","journal-title":"Front Biosci Elite Ed"},{"key":"10.1016\/j.joco.2016.09.009_bib44","doi-asserted-by":"crossref","first-page":"563","DOI":"10.2147\/OPTH.S59724","article-title":"Recent developments in the management of dry age-related macular degeneration","volume":"9","author":"Buschini","year":"2015","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.joco.2016.09.009_bib45","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.neuroscience.2009.02.084","article-title":"Neuronal and glial cell expression of angiotensin II type 1 (AT1) and type 2 (AT2) receptors in the rat retina","volume":"161","author":"Downie","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.joco.2016.09.009_bib46","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.preteyeres.2010.03.003","article-title":"The renin-angiotensin system in retinal health and disease: its influence on neurons, glia and the vasculature","volume":"29","author":"Fletcher","year":"2010","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.joco.2016.09.009_bib47","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1159\/000310835","article-title":"Expression and localization of angiotensin II type I receptor mRNA in rat ocular tissues","volume":"211","author":"Murata","year":"1997","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.joco.2016.09.009_bib48","doi-asserted-by":"crossref","first-page":"3387","DOI":"10.1046\/j.1460-9568.1999.00787.x","article-title":"Angiotensin II receptor subtype gene expression and cellular localization in the retina and non-neuronal ocular tissues of the rat","volume":"11","author":"Wheeler-Schilling","year":"1999","journal-title":"Euro J Neurosci"},{"key":"10.1016\/j.joco.2016.09.009_bib49","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1167\/iovs.07-1399","article-title":"Angiotensin (1\u20137) reduces intraocular pressure in the normotensive rabbit eye","volume":"49","author":"Vaajanen","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.joco.2016.09.009_bib50","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/j.1755-3768.2009.01563.x","article-title":"Angiotensin receptors in the eyes of arterial hypertensive rats","volume":"88","author":"Vaajanen","year":"2010","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.joco.2016.09.009_bib51","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1007\/s00417-015-2952-z","article-title":"The expression of Mas-receptor of the renin\u2013angiotensin system in the human eye","volume":"253","author":"Vaajanen","year":"2015","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.joco.2016.09.009_bib52","series-title":"Central actions of Angiotensin and Related Hormones","first-page":"23","article-title":"Angiotensin I converting enzyme activity in the choroid plexus and in the retinal","author":"Igic","year":"1977"},{"key":"10.1016\/j.joco.2016.09.009_bib53","first-page":"529","article-title":"The physiological significance of the alternative pathways of angiotensin II production","volume":"57","author":"Kramkowski","year":"2006","journal-title":"J\u00a0Physiol Pharmacol"},{"key":"10.1016\/j.joco.2016.09.009_bib54","doi-asserted-by":"crossref","first-page":"8258","DOI":"10.1073\/pnas.1432869100","article-title":"Angiotensin (1\u20137) is an endogenous ligand for the G-protein-coupled receptor Mas","volume":"8","author":"Santos","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.joco.2016.09.009_bib55","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1161\/01.CIR.0000160867.23556.7D","article-title":"G-protein-coupled receptor Mas is a physiological antagonist of the angiotensin II type I receptor","volume":"111","author":"Kostenis","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.joco.2016.09.009_bib56","doi-asserted-by":"crossref","first-page":"e49624","DOI":"10.1371\/journal.pone.0049624","article-title":"Angiotensin-2-mediated Ca2+ signaling in the retinal pigment epithelium: role of angiotensin-receptor-associated-protein and TRPV2 channel","volume":"7","author":"Barro-Soria","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.joco.2016.09.009_bib57","doi-asserted-by":"crossref","first-page":"F785","DOI":"10.1152\/ajprenal.00372.2004","article-title":"Angiotensin II Ca2+signaling in rat afferent arterioles: stimulation of cyclic ADP ribose and IP3 pathways","volume":"288","author":"Fellner","year":"2005","journal-title":"Am J Physiol Ren Physiol"},{"key":"10.1016\/j.joco.2016.09.009_bib58","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1016\/j.diabres.2007.09.023","article-title":"The eyes in diabetes and diabetes through the eyes","volume":"78S","author":"Boehm","year":"2007","journal-title":"Diabetes Res Clin Prac"},{"key":"10.1016\/j.joco.2016.09.009_bib59","first-page":"35","article-title":"Pathophysiology of diabetic retinopathy","volume":"34","author":"Tarr","year":"2013","journal-title":"ISRN Ophthalmol"},{"key":"10.1016\/j.joco.2016.09.009_bib60","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1046\/j.1475-1313.2003.00134.x","article-title":"Pathogenesis of diabetic retinopathy and the renin angiotensin system","volume":"23","author":"Funastu","year":"2003","journal-title":"Ophthalmic Physiol Opt"},{"key":"10.1016\/j.joco.2016.09.009_bib61","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1007\/s001250051539","article-title":"Angiotensin converting enzyme inhibition reduces retinal overexpression of vascular endothelial growth factor and hyperpermeability in experimental diabetes","volume":"43","author":"Gilbert","year":"2000","journal-title":"Diabetologia"},{"key":"10.1016\/j.joco.2016.09.009_bib62","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1161\/01.HYP.36.6.1099","article-title":"Retinal neovascularization is prevented by blockade of the renin-angiotensin system","volume":"36","author":"Moravski","year":"2000","journal-title":"Hypertension"},{"key":"10.1016\/j.joco.2016.09.009_bib63","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1007\/s001250100556","article-title":"The angiotensin II receptor antagonist candesartan cilexetil (TCV-116) ameliorates retinal disorders in rats","volume":"44","author":"Nagisa","year":"2001","journal-title":"Diabetologia"},{"key":"10.1016\/j.joco.2016.09.009_bib64","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1038\/sj.jhh.1001438","article-title":"The retinal renin-angiotensin system: implications for therapy in diabetic retinopathy","volume":"16","author":"Sjolie","year":"2002","journal-title":"J\u00a0Hum Hypertens"},{"key":"10.1016\/j.joco.2016.09.009_bib65","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.2337\/db07-1281","article-title":"Angiotensin II type 1 receptor signaling contributes to synaptophysin degradation and neuronal dysfunction in the diabetic retina","volume":"57","author":"Kurihara","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.joco.2016.09.009_bib66","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1016\/j.ajpath.2011.02.006","article-title":"Angiotensin II-induced MMP-2 activity and MMP-14 and basigin protein expression are mediated via angiotensin II receptor type 1-mitogen-activated protein kinase 1 pathway in retinal pigment epithelium","volume":"178","author":"Pons","year":"2011","journal-title":"Am J Pathol"},{"key":"10.1016\/j.joco.2016.09.009_bib67","doi-asserted-by":"crossref","first-page":"4342","DOI":"10.1167\/iovs.06-1473","article-title":"Suppression of diabetes induced retinal inflammation by blocking the angiotensin II type 1 receptor or its downstream nuclear factor-kappaB pathway","volume":"48","author":"Nagai","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.joco.2016.09.009_bib68","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.2337\/db09-0604","article-title":"(Pro)renin receptor: a treatment target for diabetic retinopathy?","volume":"58","author":"Wilkinson-Berka","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.joco.2016.09.009_bib69","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1007\/s11064-013-1058-4","article-title":"Telmisartan ameliorates neurotrophic support and oxidative stress in the retina of streptozotocin-induced diabetic rats","volume":"38","author":"Ola","year":"2013","journal-title":"Neurochem Res"},{"key":"10.1016\/j.joco.2016.09.009_bib70","doi-asserted-by":"crossref","first-page":"3208","DOI":"10.2337\/db10-0552","article-title":"Candesartan attenuates diabetic retinal vascular pathology by restoring glyoxalase-I function","volume":"59","author":"Miller","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.joco.2016.09.009_bib71","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.biocel.2005.08.002","article-title":"Angiotensin and diabetic retinopathy","volume":"38","author":"Wilkinson-Berka","year":"2006","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.joco.2016.09.009_bib72","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.2353\/ajpath.2008.080757","article-title":"Prorenin and the (pro)renin receptor in ocular pathology","volume":"173","author":"Wilkinson-Berka","year":"2008","journal-title":"Am J Pathol"},{"key":"10.1016\/j.joco.2016.09.009_bib73","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1172\/JCI21398","article-title":"Inhibition of diabetic nephropathy by a decoy peptide corresponding to the \u201chandle\u201d region for nonproteolytic activation of prorenin","volume":"114","author":"Ichihara","year":"2004","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.joco.2016.09.009_bib74","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1172\/JCI0214276","article-title":"Pivotal role of the renin\/prorenin receptor in angiotensin II production and cellular responses to renin","volume":"109","author":"Nguyen","year":"2002","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.joco.2016.09.009_bib75","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/sj.ki.5002243","article-title":"Renin-stimulated TGF-beta1 expression is regulated by a mitogen-activated protein kinase in mesangial cells","volume":"72","author":"Huang","year":"2007","journal-title":"Kidney Int"},{"key":"10.1016\/j.joco.2016.09.009_bib76","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1681\/ASN.2006091062","article-title":"Slowly progressive, angiotensin II-independent glomerulosclerosis in human (pro)renin receptor-transgenic rats","volume":"18","author":"Kaneshiro","year":"2007","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.joco.2016.09.009_bib77","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1167\/iovs.06-0534","article-title":"Role of nonproteolytically activated prorenin in pathologic, but not physiologic, retinal neovascularization","volume":"48","author":"Satofuka","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.joco.2016.09.009_bib78","unstructured":"Vision 2020: The Right to Sight. Global Initiative for the Elimination of Avoidable Blindness: Action Plan 2006\u20132011. World Health Organization. http:\/\/www.who.int\/blindness\/Vision2020_report.pdf."},{"key":"10.1016\/j.joco.2016.09.009_bib79","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s00125-001-0747-8","article-title":"Angiotensin converting enzyme inhibiting therapy is associated with lower vitreous vascular endothelial growth factor concentrations in patients with proliferative diabetic retinopathy","volume":"45","author":"Hogeboom","year":"2002","journal-title":"Diabetologia"},{"key":"10.1016\/j.joco.2016.09.009_bib80","doi-asserted-by":"crossref","first-page":"954","DOI":"10.2337\/db07-1524","article-title":"Protective effect of perindopril on diabetic retinopathy is associated with decreased vascular endothelial growth factor-to-pigment epithelium-derived factor ratio: involvement of a mitochondria-reactive oxygen species pathway","volume":"58","author":"Zheng","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.joco.2016.09.009_bib81","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.exer.2007.06.008","article-title":"Angiotensin II receptor blocker inhibits abnormal accumulation of advanced glycation end products and retinal damage in a rat model of type 2 diabetes","volume":"85","author":"Sugiyama","year":"2007","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.joco.2016.09.009_bib82","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1177\/1470320314566018","article-title":"Retinal ganglion cell neuroprotection by an angiotensin II blocker in an ex\u00a0vivo retinal explant model","volume":"16","author":"White","year":"2015","journal-title":"J\u00a0Renin Angiotensin Aldosterone Syst"},{"key":"10.1016\/j.joco.2016.09.009_bib83","first-page":"224","article-title":"MicroRNA-152 represses VEGF and TGF\u03b21 expressions through post-transcriptional inhibition of (Pro)renin receptor in human retinal endothelial cells","volume":"21","author":"Haque","year":"2015","journal-title":"Mol Vis"},{"key":"10.1016\/j.joco.2016.09.009_bib84","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.tjo.2013.04.004","article-title":"The vitreous renin\u2013angiotensin system is mediated by soluble (pro)renin receptor in diabetic retinopathy: a new implication of the receptor-associated prorenin system","volume":"3","author":"Kanda","year":"2013","journal-title":"Taiwan J Ophthalmol"},{"key":"10.1016\/j.joco.2016.09.009_bib85","doi-asserted-by":"crossref","first-page":"3104","DOI":"10.1007\/s00125-012-2702-2","article-title":"(Pro)renin receptor is associated with angiogenic activity in proliferative diabetic retinopathy","volume":"55","author":"Kanda","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/j.joco.2016.09.009_bib86","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.2337\/db08-0254","article-title":"(Pro)renin receptor\u2013mediated signal transduction and tissue renin-angiotensin system contribute to diabetes-induced retinal inflammation","volume":"58","author":"Satofuka","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.joco.2016.09.009_bib87","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1590\/1414-431X20154583","article-title":"Activation of endogenous angiotensin converting enzyme 2 prevents early injuries induced by hyperglycemia in rat retina","volume":"48","author":"Foureaux","year":"2015","journal-title":"Braz J Med Bio Res"},{"key":"10.1016\/j.joco.2016.09.009_bib88","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1136\/bjo.86.6.676","article-title":"Renin-angiotensin system expression and secretory function in cultured human ciliary body non-pigmented epithelium","volume":"86","author":"Cullinane","year":"2002","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.joco.2016.09.009_bib89","first-page":"209","article-title":"Effects of angiotensin II on the 3H-TdR incorporation and synthesis of collagen in cultured bovine trabecular meshwork cells (article in Chinese)","volume":"17","author":"Shen","year":"2001","journal-title":"Yan Ke Xue Bao"},{"key":"10.1016\/j.joco.2016.09.009_bib90","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1076\/ceyr.23.2.139.5470","article-title":"The effect of angiotensin II on uveoscleral outflow in rabbits","volume":"23","author":"Inoue","year":"2001","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.joco.2016.09.009_bib91","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1139\/Y10-026","article-title":"Oculohypotensive effect of perindopril in acute and chronic models of glaucoma in rabbits","volume":"88","author":"Mehta","year":"2010","journal-title":"Can J Physiol Pharmacol"},{"key":"10.1016\/j.joco.2016.09.009_bib92","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/00005344-200008000-00005","article-title":"Oculohypotensive effect of angiotensin-converting enzyme inhibitors in acute and chronic models of glaucoma","volume":"36","author":"Shah","year":"2000","journal-title":"J\u00a0Cardiovasc Pharm"},{"key":"10.1016\/j.joco.2016.09.009_bib93","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1006\/exer.2000.0866","article-title":"Effect of oral losartan potassium on intraocular pressure in normotensive and glaucomatous human subjects","volume":"71","author":"Costagliola","year":"2000","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.joco.2016.09.009_bib94","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.exer.2004.11.012","article-title":"Effect of CS-088, an angiotensin AT1 receptor antagonist, on intraocular pressure in glaucomatous monkey eyes","volume":"80","author":"Wang","year":"2005","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.joco.2016.09.009_bib95","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/jop.1990.6.1","article-title":"Prostaglandins mediate the ocular hypotensive action of the angiotensin converting enzyme inhibitor MK-422 (enalaprilat) in African green monkeys","volume":"6","author":"Lotti","year":"1990","journal-title":"J\u00a0Ocul Pharmacol"},{"key":"10.1016\/j.joco.2016.09.009_bib96","doi-asserted-by":"crossref","first-page":"3967","DOI":"10.1167\/iovs.03-0088","article-title":"Relationship between ciliary body blood flow and aqueous production in rabbits","volume":"44","author":"Reitsamer","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.joco.2016.09.009_bib97","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1089\/jop.2014.0114","article-title":"Novel potential treatment modalities for ocular hypertension: focus on angiotensin and bradykinin system axes","volume":"31","author":"Sharif","year":"2015","journal-title":"J\u00a0Ocul Pharmacol Ther"},{"key":"10.1016\/j.joco.2016.09.009_bib98","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1167\/iovs.06-1296","article-title":"Suppression of choroidal neovascularization by inhibiting angiotensin-converting enzyme: minimal role of bradykinin","volume":"48","author":"Nagai","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.joco.2016.09.009_bib99","first-page":"403","article-title":"Lifestyle-related diseases and anti-aging ophthalmology: suppression of retinal and choroidal pathologies by inhibiting renin-angiotensin system and inflammation","volume":"113","author":"Ishida","year":"2009","journal-title":"Nihon Ganka Gakkai Zasshi"},{"key":"10.1016\/j.joco.2016.09.009_bib100","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.2353\/ajpath.2008.080457","article-title":"(Pro)renin receptor promotes choroidal neovascularization by activating its signal transduction and tissue renin angiotensin system","volume":"173","author":"Satofuka","year":"2008","journal-title":"Am J Pathol"},{"key":"10.1016\/j.joco.2016.09.009_bib101","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1161\/01.ATV.0000240050.15321.fe","article-title":"Angiotensin II type 1 receptor-mediated inflammation is required for choroidal neovascularization","volume":"26","author":"Nagai","year":"2006","journal-title":"Arterioscler Thromb Vasc Bio"},{"key":"10.1016\/j.joco.2016.09.009_bib102","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1167\/iovs.04-1476","article-title":"Suppression of ocular inflammation in endotoxin-induced uveitis by blocking the angiotensin II type 1 receptor","volume":"46","author":"Nagai","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.joco.2016.09.009_bib103","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1167\/iovs.08-2649","article-title":"Suppression of experimental autoimmune uveitis by angiotensin II type 1receptor blocker telmisartan","volume":"50","author":"Okunuki","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.joco.2016.09.009_bib104","doi-asserted-by":"crossref","first-page":"5545","DOI":"10.1167\/iovs.06-0478","article-title":"Neuroprotective effects of angiotensin II type 1 receptor (AT1R) blocker, telmisartan, via modulating AT1R and AT2R signaling in retinal inflammation","volume":"47","author":"Kurihara","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.joco.2016.09.009_bib105","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/s00417-007-0730-2","article-title":"Anti-inflammatory effect of angiotensin type 1 receptor antagonist on endotoxin-induced uveitis in rats","volume":"246","author":"Miyazaki","year":"2008","journal-title":"Graefe's Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.joco.2016.09.009_bib106","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1167\/iovs.04-1101","article-title":"Selective suppression of pathologic, but not physiologic, retinal neovascularization by blocking the angiotensin II type 1 receptor","volume":"46","author":"Nagai","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.joco.2016.09.009_bib107","doi-asserted-by":"crossref","first-page":"3809","DOI":"10.1167\/iovs.14-13883","article-title":"Angiotensin-converting enzyme 2 (ACE2) activator dize ameliorates endotoxin-induced uveitis in mice","volume":"55","author":"Qiu","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.joco.2016.09.009_bib108","first-page":"123","article-title":"Hypertension potentiates cataractogenesis in rat eye through modulation of oxidative stress and electrolyte homeostasis","volume":"28","author":"Khan","year":"2016","journal-title":"J\u00a0Curr Ophthalmol"},{"key":"10.1016\/j.joco.2016.09.009_bib109","first-page":"BR334","article-title":"Influence of selected angiotensin-converting enzyme inhibitors on alloxan-induced diabetic cataract in rabbits","volume":"15","author":"Jablecka","year":"2009","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.joco.2016.09.009_bib110","doi-asserted-by":"crossref","first-page":"107","DOI":"10.4103\/0253-7613.24615","article-title":"In\u00a0vitro prevention by ACE inhibitors of cataract induced by glucose","volume":"38","author":"Langade","year":"2006","journal-title":"Indian J Pharmacol"},{"key":"10.1016\/j.joco.2016.09.009_bib111","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.2337\/dc11-0476","article-title":"Benefits of renin-angiotensin blockade on retinopathy in type 1 diabetes vary with glycemic control","volume":"34","author":"Harindhanavudhi","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.joco.2016.09.009_bib112","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.1742-1241.2010.02552.x","article-title":"Does renin-angiotensin system blockade have a role in preventing diabetic retinopathy? A clinical review","volume":"65","author":"Sjolie","year":"2011","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.joco.2016.09.009_bib113","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1161\/01.RES.82.5.619","article-title":"Angiotensin II potentiates vascular endothelial growth factor-induced angiogenic activity in retinal microcapillary endothelial cells","volume":"82","author":"Otani","year":"1998","journal-title":"Circ Res"},{"key":"10.1016\/j.joco.2016.09.009_bib114","first-page":"1192","article-title":"Angiotensin II-stimulated potentiates vascular endothelial growth factor expression in bovine retinal pericytes","volume":"41","author":"Otani","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.joco.2016.09.009_bib115","doi-asserted-by":"crossref","first-page":"i29","DOI":"10.1136\/heart.84.suppl_1.i29","article-title":"Modulation of renin-angiotensin system and retinopathy","volume":"84","author":"Chaturvedi","year":"2000","journal-title":"Heart"},{"key":"10.1016\/j.joco.2016.09.009_bib116","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1097\/01.hjh.0000220410.69116.f8","article-title":"Role of the angiotensin II type 1 receptor in the pathogenesis of diabetic retinopathy: effects of blood pressure control and beyond","volume":"24","author":"Clermont","year":"2006","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.joco.2016.09.009_bib117","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1056\/NEJMoa0808400","article-title":"Renal and retinal effects of enalapril and losartan in type 1 diabetes","volume":"361","author":"Mauer","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.joco.2016.09.009_bib118","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.amjhyper.2006.09.018","article-title":"Valsartan but not atenolol improves vascular pathology in diabetic ren-2 rat retina","volume":"20","author":"Wilkinson-Berka","year":"2007","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.joco.2016.09.009_bib119","first-page":"141","article-title":"Neovascularization produced by angiotensin II","volume":"105","author":"Fernandez","year":"1985","journal-title":"J\u00a0Lab Clin Med"},{"key":"10.1016\/j.joco.2016.09.009_bib120","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.2337\/diab.46.9.1473","article-title":"Vascular endothelial growth factor-induced retinal permeability is mediated by protein kinase C in\u00a0vivo and suppressed by an orally effective beta-isoform-selective inhibitor","volume":"46","author":"Aiello","year":"1997","journal-title":"Diabetes"},{"key":"10.1016\/j.joco.2016.09.009_bib121","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0002-9394(02)01323-5","article-title":"Angiotensin II and vascular endothelial growth factor in the vitreous fluid of patients with diabetic macular edema and other retinal disorders","volume":"133","author":"Funatsu","year":"2002","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.joco.2016.09.009_bib122","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1136\/bjo.86.3.311","article-title":"Angiotensin II and vascular endothelial growth factor in the vitreous fluid of patients with proliferative diabetic retinopathy","volume":"86","author":"Funatsu","year":"2002","journal-title":"Bri J Ophthalmol"},{"key":"10.1016\/j.joco.2016.09.009_bib123","first-page":"1362","article-title":"Prorenin and renin levels in the vitreous of human eyes with and without proliferative diabetic retinopathy","volume":"33","author":"Schiffman","year":"1992","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.joco.2016.09.009_bib124","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S1056-8727(02)00188-5","article-title":"Angiotensin-converting enzyme inhibition for the treatment of moderate to severe diabetic retinopathy in normotensive type 2 diabetic patients a pilot study","volume":"16","author":"Pradhan","year":"2002","journal-title":"J\u00a0Diabetes Complications"},{"key":"10.1016\/j.joco.2016.09.009_bib125","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1016\/S0140-6736(08)61412-9","article-title":"Direct programme study group. Effect of candesartan on prevention (Direct Prevent 1) and progression (Direct Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trials","volume":"372","author":"Chaturvedi","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.joco.2016.09.009_bib126","first-page":"1017","article-title":"Vascular endothelial growth factor and its receptors in control and diabetic rat eyes","volume":"78","author":"Gilbert","year":"1998","journal-title":"Lab Invest"},{"key":"10.1016\/j.joco.2016.09.009_bib127","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1742-7843.2011.00729.x","article-title":"Local ocular renin\u2013angiotensin system \u2013 a target for glaucoma therapy?","volume":"9","author":"Vaajanen","year":"2011","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1016\/j.joco.2016.09.009_bib128","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/00061198-199806000-00004","article-title":"Changing definition of glaucoma","volume":"7","author":"Bathija","year":"1998","journal-title":"J\u00a0Glaucoma"},{"key":"10.1016\/j.joco.2016.09.009_bib129","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/S0161-6420(00)00138-X","article-title":"Vascular risk factors for primary open angle glaucoma: the Enga-Neumarkt study","volume":"107","author":"Bonomi","year":"2000","journal-title":"Ophthalmology"},{"key":"10.1016\/j.joco.2016.09.009_bib130","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0002-9394(01)00964-3","article-title":"Collaborative normal-tension glaucoma study group. Risk factors for progression of visual field abnormalities in normal-tension glaucoma","volume":"131","author":"Drance","year":"2001","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.joco.2016.09.009_bib131","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1097\/00061198-199906000-00012","article-title":"Vascular dysregulation: a principal risk factor for glaucomatous damage?","volume":"8","author":"Flammer","year":"1999","journal-title":"J\u00a0Glaucoma"},{"key":"10.1016\/j.joco.2016.09.009_bib132","doi-asserted-by":"crossref","first-page":"e0141137","DOI":"10.1371\/journal.pone.0141137","article-title":"Losartan treatment protects retinal ganglion cells and alters scleral remodeling in experimental glaucoma","volume":"10","author":"Quigley","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.joco.2016.09.009_bib133","doi-asserted-by":"crossref","first-page":"5800","DOI":"10.1167\/iovs.09-3678","article-title":"Neuroprotective effects of angiotensin II type 1 receptor blocker in a rat model of chronic glaucoma","volume":"50","author":"Yang","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.joco.2016.09.009_bib134","doi-asserted-by":"crossref","first-page":"3586","DOI":"10.1167\/iovs.03-0038","article-title":"Macrophage depletion diminishes lesion size and severity in experimental choroidal neovascularization","volume":"44","author":"Espinosa-Heidmann","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.joco.2016.09.009_bib135","doi-asserted-by":"crossref","first-page":"3578","DOI":"10.1167\/iovs.03-0097","article-title":"Macrophage depletion inhibits experimental choroidal neovascularization","volume":"44","author":"Sakurai","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.joco.2016.09.009_bib136","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1189\/jlb.0902436","article-title":"The critical role of ocular-infiltrating macrophages in the development of choroidal neovascularization","volume":"74","author":"Tsutsumi","year":"2003","journal-title":"J\u00a0Leukoc Biol"},{"key":"10.1016\/j.joco.2016.09.009_bib137","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1056\/NEJMoa042760","article-title":"Pegaptanib for neovascular age-related macular degeneration","volume":"351","author":"Gragoudas","year":"2004","journal-title":"New Engl J Med"},{"key":"10.1016\/j.joco.2016.09.009_bib138","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1056\/NEJMoa054481","article-title":"Ranibizumab for neovascular age-related macular degeneration","volume":"355","author":"Rosenfeld","year":"2006","journal-title":"New Engl J Med"},{"key":"10.1016\/j.joco.2016.09.009_bib139","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.exer.2009.02.020","article-title":"Angiotensin II induced hypertension regulates AT1 receptor subtypes and extracellular matrix turnover in mouse retinal pigment epithelium","volume":"89","author":"Praddaude","year":"2009","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.joco.2016.09.009_bib140","doi-asserted-by":"crossref","first-page":"C1633","DOI":"10.1152\/ajpcell.00092.2008","article-title":"Regulation of angiotensin II receptors and extracellular matrix turnover in human retinal pigment epithelium: role of angiotensin II","volume":"295","author":"Striker","year":"2008","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.joco.2016.09.009_bib141","doi-asserted-by":"crossref","first-page":"3581","DOI":"10.1161\/01.CIR.0000148824.93600.F3","article-title":"Angiotensin II induces neutrophil accumulation in\u00a0vivo through generation and release of CXC chemokines","volume":"110","author":"Nabah","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.joco.2016.09.009_bib142","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.exer.2009.06.014","article-title":"(Pro)renin receptor is expressed in human retinal pigment epithelium and participates in extracellular matrix remodeling","volume":"89","author":"Alcazar","year":"2009","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.joco.2016.09.009_bib143","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1096\/fj.02-0755fje","article-title":"Control of dendritic cell differentiation by angiotensin II","volume":"17","author":"Nahmod","year":"2003","journal-title":"FASEB J"},{"key":"10.1016\/j.joco.2016.09.009_bib144","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1161\/01.CIR.100.15.1646","article-title":"Angiotensin II stimulates intercellular adhesion molecule-1 (ICAM-1) expression by human vascular endothelial cells and increases soluble ICAM-1 release in\u00a0vivo","volume":"100","author":"Pastore","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.joco.2016.09.009_bib145","doi-asserted-by":"crossref","first-page":"175","DOI":"10.4103\/0301-4738.49390","article-title":"Advances in pharmacological strategies for the prevention of cataract development","volume":"57","author":"Gupta","year":"2009","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.joco.2016.09.009_bib146","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1167\/iovs.10-6373","article-title":"Metabolic syndrome components and age-related cataract: the Singapore Malay eye study","volume":"52","author":"Sabanayagam","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.joco.2016.09.009_bib147","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1167\/iovs.06-0892","article-title":"Retinal dysfunction in diabetic ren-2 rats is ameliorated by treatment with valsartan but not atenolol","volume":"48","author":"Phipps","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.joco.2016.09.009_bib148","doi-asserted-by":"crossref","first-page":"243","DOI":"10.3317\/jraas.2002.045","article-title":"The renin-angiotensin-aldosterone system and the eye in diabetes","volume":"3","author":"Strain","year":"2002","journal-title":"J\u00a0Renin Angiotensin Aldosterone Syst"}],"container-title":["Journal of Current Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452232516301135?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452232516301135?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,1,9]],"date-time":"2021-01-09T17:40:24Z","timestamp":1610214024000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452232516301135"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":148,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["S2452232516301135"],"URL":"https:\/\/doi.org\/10.1016\/j.joco.2016.09.009","relation":{},"ISSN":["2452-2325"],"issn-type":[{"value":"2452-2325","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic targets of renin-angiotensin system in ocular disorders","name":"articletitle","label":"Article Title"},{"value":"Journal of Current Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.joco.2016.09.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016, Iranian Society of Ophthalmology. Production and hosting by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}